title: The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience.
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK. aisling.higham@nhs.net.
authors.forename: Aisling
authors.identifier: http://orcid.org/0000-0002-8901-0007
authors.initials: A
authors.lastname: Higham
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK.
authors.forename: Sarita
authors.initials: S
authors.lastname: Jacob
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK.
authors.forename: Miriam
authors.initials: M
authors.lastname: Cox
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK.
authors.forename: Catherine
authors.initials: C
authors.lastname: Baker
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK.
authors.forename: Sahar
authors.initials: S
authors.lastname: Al-Husainy
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Sivaraj
authors.affiliation: Department of Ophthalmology, Heart of England Foundation Trust, Birmingham, West Midlands, UK.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Gibson
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage* / Q000009:adverse effects; D004343:Drug Implants; D057915:Drug Substitution; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000069579:Ranibizumab / Q000627:therapeutic use; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D004343:Drug Implants; D005938:Glucocorticoids; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D003907:Dexamethasone; D000069579:Ranibizumab